RECRUITING

Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology

Talk to us

Conditions

Hip Dysplasia

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

At present, it is not clear whether performing a hip arthroscopy at the same time as a PAO improves patient outcomes after surgery compared to a PAO alone. This research project will randomize patients to receive either a PAO alone, or a PAO and a hip arthroscopy at the same time.

Official Title

Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology: A Multicenter Randomized Controlled Trial

Quick Facts

Study Start:2018-04-04
Study Completion:2024-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03481010

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:16 Years to 50 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * Skeletally mature patient undergoing Bernese periacetabular osteotomy for symptomatic acetabular dysplasia/hip instability
  2. * Pre-Operative MRI at 3T and/or gadolinium MR arthrogram
  3. * Age, 16-50 years old
  4. * Patient capable of giving informed consent
  1. * Prior hip/pelvis surgery of any kind on the surgical side
  2. * Prior hip arthroplasty surgery on either side
  3. * Radiographic evidence of arthritis (i.e. Tönnis grade =2)
  4. * Known connective tissue disorder (e.g. Ehlers-Danlos Syndrome, etc.)
  5. * Known neuromuscular disorder (e.g. Cerebral Palsy, Spina bifida, etc.)
  6. * Known skeletal dysplasia (e.g. Achondroplasia, Multiple Epiphyseal Dysplasia, etc.)
  7. * Cognitive impairment that prevents accurate completion of patient-reported outcome questionnaires.
  8. * Patient unable/unwilling to complete all required follow-up visits
  9. * Concurrent proximal femoral osteotomy and/or surgical hip dislocation

Contacts and Locations

Study Contact

Geoffrey Wilkin, MD
CONTACT
613-798-5555
gwilkin@toh.ca
Cheryl Kreviazuk
CONTACT
613-737-8920
ckreviazuk@ohri.ca

Principal Investigator

Geoffrey Wilkin, MD
PRINCIPAL_INVESTIGATOR
The Ottawa Hospital Research Institute

Study Locations (Sites)

Northwestern University
Chicago, Illinois, 60611
United States
William Beaumont Hospital
Royal Oak, Michigan, 48073
United States
The Washington University
Saint Louis, Missouri, 63130
United States
Hospital for Special Surgery
New York, New York, 10021
United States

Collaborators and Investigators

Sponsor: Ottawa Hospital Research Institute

  • Geoffrey Wilkin, MD, PRINCIPAL_INVESTIGATOR, The Ottawa Hospital Research Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2018-04-04
Study Completion Date2024-12-31

Study Record Updates

Study Start Date2018-04-04
Study Completion Date2024-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Hip Dysplasia